Biodesix (NASDAQ:BDSX) and Alignment Healthcare (NASDAQ:ALHC) Head to Head Analysis

Biodesix (NASDAQ:BDSX) and Alignment Healthcare (NASDAQ:ALHC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, dividends and profitability.

Valuation & Earnings

This table compares Biodesix and Alignment Healthcare”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$71.32 million	1.07	-$42.93 million	($0.29)	-1.80
Alignment Healthcare	$2.70 billion	1.20	-$128.04 million	($0.28)	-58.75

Biodesix has higher earnings, but lower revenue than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are owned by institutional investors. 30.1% of Biodesix shares are owned by company insiders. Comparatively, 7.0% of Alignment Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings for Biodesix and Alignment Healthcare, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	0	1	4	0	2.80
Alignment Healthcare	0	4	6	1	2.73

Biodesix presently has a consensus price target of $1.75, suggesting a potential upside of 235.51%. Alignment Healthcare has a consensus price target of $18.83, suggesting a potential upside of 14.49%. Given Biodesix’s stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Alignment Healthcare.

Volatility and Risk

Biodesix has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Alignment Healthcare has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500.

Profitability

This table compares Biodesix and Alignment Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biodesix	-53.66%	-269.67%	-43.94%
Alignment Healthcare	-1.53%	-43.68%	-6.05%

Summary

Alignment Healthcare beats Biodesix on 10 of the 15 factors compared between the two stocks.

About Biodesix

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.